Quantum-safe data protection for clinical trial datasets, regulatory submissions, and pharmaceutical IP.
Half-day workshop on quantum threats to pharmaceutical IP and clinical trial data. Covers HNDL threat modelling, 21 CFR Part 11, EU Annex 11, CRO supply chain security, and board-level IP exposure quantification for pharma and life sciences.
Course content is structured into sessions below. Each session is configurable to your organisation's environment, threat model, and objectives.
| # | Session | Topics |
|---|---|---|
| 1 | The Pharma HNDL Threat What the WEF September 2025 assessment means for your organisation | |
| 2 | Clinical Trial Data Classification Exercise Mapping your highest-exposure datasets |
|
| Break | ||
| 3 | Regulatory Deep Dive 21 CFR Part 11, EU Annex 11, and GxP data integrity under PQC |
|
| 4 | Supply Chain Security Extending PQC requirements to CROs and academic partners |
|
| 5 | Board-Ready IP Exposure Model Quantifying pharmaceutical quantum risk in financial terms |
|
| 6 | Q&A and Implementation Planning | |
Training courses are designed and delivered by QSECDEF in collaboration with subject specialists. All instructors have direct experience in quantum technologies and security.
Course design and delivery
QSECDEF brings expertise in post-quantum cryptography, quantum computing strategy, and defence-grade security assessment. Our membership spans 900+ organisations and 1,500+ professionals working at the intersection of quantum technologies and critical infrastructure security.
Get in touch to discuss scheduling, group pricing, and how this course can be configured to your organisation's needs.
Contact Us